Omega-3 Fatty Acids, Hepatic Lipid Metabolism, and Nonalcoholic Fatty Liver Disease
Top Cited Papers
- 17 July 2013
- journal article
- review article
- Published by Annual Reviews in Annual Review of Nutrition
- Vol. 33 (1) , 231-248
Abstract
Long-chain omega-3 fatty acids belong to a family of polyunsaturated fatty acids that are known to have important beneficial effects on metabolism and inflammation. Such effects may confer a benefit in specific chronic noncommunicable diseases that are becoming very prevalent in Westernized societies [e.g., nonalcoholic fatty liver disease (NAFLD)]. Typically, with a Westernized diet, long-chain omega-6 fatty acid consumption is markedly greater than omega-3 fatty acid consumption. The potential consequences of an alteration in the ratio of omega-6 to omega-3 fatty acid consumption are increased production of proinflammatory arachidonic acid–derived eicosanoids and impaired regulation of hepatic and adipose function, predisposing to NAFLD. NAFLD represents a spectrum of liver fat–related conditions that originates with ectopic fat accumulation in liver (hepatic steatosis) and progresses, with the development of hepatic inflammation and fibrosis, to nonalcoholic steatohepatitis (NASH). If the adipose tissue is inflamed with widespread macrophage infiltration, the production of adipokines may act to exacerbate liver inflammation and NASH. Omega-3 fatty acid treatment may have beneficial effects in regulating hepatic lipid metabolism, adipose tissue function, and inflammation. Recent studies testing the effects of omega-3 fatty acids in NAFLD are showing promise and suggesting that these fatty acids may be useful in the treatment of NAFLD. To date, further research is needed in NAFLD to (a) establish the dose of long-chain omega-3 fatty acids as a treatment, (b) determine the duration of therapy, and (c) test whether there is benefit on the different component features of NAFLD (hepatic fat, inflammation, and fibrosis).Keywords
This publication has 90 references indexed in Scilit:
- Endogenously synthesized n-3 polyunsaturated fatty acids in fat-1 mice ameliorate high-fat diet-induced non-alcoholic fatty liver diseaseBiochemical Pharmacology, 2012
- Fish oil — How does it reduce plasma triglycerides?Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
- Gut triglyceride productionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
- The role of adipose tissue in mediating the beneficial effects of dietary fish oilThe Journal of Nutritional Biochemistry, 2011
- Overexpression of Cholesterol 7α-Hydroxylase Promotes Hepatic Bile Acid Synthesis and Secretion and Maintains Cholesterol Homeostasis ΔHepatology, 2010
- Resolvins and protectins: Natural pharmacophores for resolution biologyProstaglandins, Leukotrienes and Essential Fatty Acids, 2010
- Apolipoprotein C3 Gene Variants in Nonalcoholic Fatty Liver DiseaseNew England Journal of Medicine, 2010
- The essentiality of arachidonic acid and docosahexaenoic acidProstaglandins, Leukotrienes and Essential Fatty Acids, 2009
- Docosahexaenoic acid (DHA) and hepatic gene transcriptionChemistry and Physics of Lipids, 2008
- Presecretory oxidation, aggregation, and autophagic destruction of apoprotein-B: A pathway for late-stage quality controlProceedings of the National Academy of Sciences, 2008